Heights Capital Management »

Theriva Biologics shares owned by Heights Capital Management

Quarter-by-quarter ownership of Theriva Biologics shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $196k 142k 1.38

More positions owned by Heights Capital Management

Flutter Entmt SHS (FLUT)
Oatly Group Ab Note 9.250% 9/1 (Principal)
Sable Offshore Corp Com Shs (SOC)
Gp-act Iii Acquisition Corp Cl A
Future Vision Ii Acquisition Unit 06/20/2029
Flag Ship Acquisition Corp Ord Shs
Cantor Equity Partners Shs Cl A
Ib Acquisition Corp Com Shs (IBAC)
Voyager Acquisition Corp Unit 99/99/9999
Haymaker Acquisition Corp Iv Class A (HYAC)
Iron Horse Acquisitions Corp (IROH)
Cayson Acquisition Corp Unit 99/99/9999
Nyxoah S A SHS (NYXH)
Blacksky Technology Cl A New
Goldenstone Acq Crp; Tnt Acq Dt: 12/21/2023; Cash: $10.15 (GDST)

View all positions for Heights Capital Management

Top funds holding Theriva Biologics

Heights Capital Management
Frigate Ventures
MSDC Management
Hrt Financial
BlackRock
Advisor Group Holdings
Barclays
Iron Horse Wealth Management
Bank of America Corporation
Planning Capital Management Corp

View all funds holding Theriva Biologics